Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Terlipressin infusion titrated to hemodynamic response in type 1 hepatorenal syndrome
2011-002166-20Phase 4Completed
- Sponsor
- Fundació Clínic per a la Recerca Biomèdica
- Start
- Jan 2012
- Modality
- Peptides
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of terlipressin in hepatorenal syndrome type 1 (HRS-1), sponsored by Fundació Clínic per a la Recerca Biomèdica. Primary endpoint: Renal function response to terlipressin. Started Jan 2012; status: completed.
02
Drugs
terlipressin
03
Conditions
hepatorenal syndrome type 1 (HRS-1)
Beyond the preview
Go deeper on 2011-002166-20.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2011-002166-20.